首页> 外文OA文献 >Preliminary Study on the Profile of Medication Use and Patient Compliance in the Treatment of Systemic Lupus Erythematosus
【2h】

Preliminary Study on the Profile of Medication Use and Patient Compliance in the Treatment of Systemic Lupus Erythematosus

机译:系统性红斑狼疮治疗中药物使用和患者依从性的初步研究

摘要

This study aimed to describe medications used and compliance in systemic lupus erythematosus (SLE) patients. This was a nonexperimental and prospective study. Patients aged ≥18 years old, used medications for SLE and consented to participate were included in this study. Data was collected from September to November 2012 by observation and interview. Pill count method was used to measure patients compliance. All of 15 patients participated in this study were female with median of age 30 years old. Three patients received single medication and the rest received combination drugs. All patients used corticosteroids. In 12 patients it was combined with 1 or 2 of disease-modifying antirheumatic drugs (DMARDs). More than 50% patients did not comply with their medications. Further research is needed to elicit barriers for noncompliance and to produce strategy for improving the medication-taking-related behaviour in SLE patients.
机译:这项研究旨在描述系统性红斑狼疮(SLE)患者使用的药物和依从性。这是一项非实验性和前瞻性研究。 ≥18岁,使用过SLE药物并同意参加的患者包括在本研究中。通过观察和访谈收集了2012年9月至2012年11月的数据。药丸计数法用于衡量患者的依从性。参加本研究的所有15名患者均为女性,中位年龄为30岁。三名患者接受了单一药物治疗,其余患者接受了联合药物治疗。所有患者均使用皮质类固醇。在12例患者中,将其与1或2种可缓解疾病的抗风湿药(DMARD)结合使用。超过50%的患者不遵守药物治疗。需要进行进一步的研究以发现违规行为的障碍,并制定出改善SLE患者服药相关行为的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号